Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis [Phase 2]
This update notes that a Phase 2 trial evaluating Tarperprumig for safety and efficacy in adults with ANCA-associated vasculitis is currentl…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Stratified Therapy on Pediatric AAGN [Phase 4]
A Phase 4 clinical trial update investigating stratified therapy for pediatric ANCA-associated vasculitis and ANCA-associated glomerulonephr…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing [Phase 4]
Phase 4 trial on intermittent rituximab dosing for maintaining remission in ANCA vasculitis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Rituximab Vasculitis Maintenance Study [Phase 3]
Phase 3 clinical trial update for rituximab maintenance in ANCA-associated vasculitis, including microscopic polyangiitis and Wegener granul…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Low-dose Glucocorticoid Vasculitis Induction Study [Phase 4]
Phase 4 clinical trial update investigating low-dose glucocorticoids for induction in vasculitis conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab [Phase 2]
A Phase 2 trial of the complement inhibitor eculizumab for anti-neutrophil cytoplasmic antibody-associated vasculitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens [Phase 2]
Phase 2 trial evaluating retinoids to silence autoantigens in ANCA-associated vasculitis was withdrawn.
-
CLINICAL_TRIALS research · 2014-07-02Clinical Trial Update: Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation
This clinical trial update discusses how different levels of ANCA positivity may correlate with vasculitis, malignancy, or chronic inflammat…